Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease. | Front Physiol | 2023 | 36711017 | PubTator, text mining | PubMed |
| A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer. | BMC Urol | 2023 | 36709279 | PubTator, text mining | PubMed |
| Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma. | Cancer Med | 2023 | 36680322 | PubTator, text mining | PubMed |
| The Beneficial Effects of Pine Nuts and Its Major Fatty Acid, Pinolenic Acid, on Inflammation and Metabolic Perturbations in Inflammatory Disorders. | Int J Mol Sci | 2023 | 36674687 | PubTator, text mining | PubMed |
| Clinical and Biological Significances of FBLN5 in Gastric Cancer. | Cancers (Basel) | 2023 | 36672502 | PubTator, text mining | PubMed |
| The variant senescence-associated secretory phenotype induced by centrosome amplification constitutes a pathway that activates hypoxia-inducible factor-1α. | Aging Cell | 2023 | 36660875 | PubTator, text mining | PubMed |
| GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. | J Crohns Colitis | 2023 | 36655602 | PubTator, text mining | PubMed |
| Immune dysregulation in immunoglobulin G4-related disease. | Jpn Dent Sci Rev | 2023 | 36654676 | PubTator, text mining | PubMed |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Proteomes | 2023 | 36648960 | PubTator, text mining | PubMed |
| Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis. | J Transl Med | 2023 | 36647141 | PubTator, text mining | PubMed |
| Mimicking Loading-Induced Cartilage Self-Heating in Vitro Promotes Matrix Formation in Chondrocyte-Laden Constructs with Different Mechanical Properties. | ACS Biomater Sci Eng | 2023 | 36625682 | PubTator, text mining | PubMed |
| Identifying novel regulators of placental development using time-series transcriptome data. | Life Sci Alliance | 2023 | 36622342 | PubTator, text mining | PubMed |
| Modeling bile duct ischemia and reoxygenation injury in human cholangiocyte organoids for screening of novel cholangio-protective agents. | EBioMedicine | 2023 | 36608526 | PubTator, text mining | PubMed |
| The genomic regulation of metastatic dormancy. | Cancer Metastasis Rev | 2023 | 36600151 | PubTator, text mining | PubMed |
| Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases. | Phytomed Plus | 2023 | 36597465 | PubTator, text mining | PubMed |
| LOXL2 reduces 5-FU sensitivity through the Hedgehog/BCL2 signaling pathway in colorectal cancer. | Exp Biol Med (Maywood) | 2023 | 36573458 | PubTator, text mining | PubMed |
| Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface. | Neural Regen Res | 2023 | 36571340 | PubTator, text mining | PubMed |
| Dissecting the influence of cellular senescence on cell mechanics and extracellular matrix formation in vitro. | Aging Cell | 2023 | 36514868 | PubTator, text mining | PubMed |
| TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling. | Cell Oncol (Dordr) | 2023 | 36512309 | PubTator, text mining | PubMed |
| "Stromal cells in prostate cancer pathobiology: friends or foes?" | Br J Cancer | 2023 | 36482187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=26